ArchivesJohn Walker2023-02-27T20:11:47-08:00

Archives

305, 2026

Prometheus Signals Near Term Development of Next Generation Noninvasive Test for MASH Patients at DDW® 2026

Chrystal Johnson2026-04-30T15:51:57-07:002026-05-03|

News & Events Prometheus Signals [...]

205, 2026

Prometheus Laboratories Showcases Drug Clearance as a Foundation for Precision Guided Biologic Dosing in IBD at DDW® 2026

Chrystal Johnson2026-05-01T11:47:13-07:002026-05-02|

News & Events Prometheus Laboratories [...]

812, 2025

Prometheus Laboratories Launches IBD Precis™ Featuring Breakthrough Colonic Markers to Transform UC and CD Assessment

Chrystal Johnson2025-12-03T15:42:01-08:002025-12-08|

News & Events Prometheus Laboratories [...]

2608, 2025

Prometheus Laboratories Announces Collaboration with Celltrion for Anser® Testing

Chrystal Johnson2025-08-25T10:53:45-07:002025-08-26|

News & Events Prometheus Laboratories [...]

2907, 2025

Prometheus Laboratories Expands Precision-Guided Dosing Tests with the Launch of PredictrPK® VDZ and UST

Chrystal Johnson2025-07-28T14:23:56-07:002025-07-29|

News & Events Prometheus Laboratories [...]

1706, 2025

PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study

Chrystal Johnson2025-06-16T13:59:16-07:002025-06-17|

News & Events PredictrPK® ADA, [...]